Lobbying Relationship

Client

CELGENE CORPORATION

More records

Lobbying firm

CELGENE CORPORATION

More records

  • H.R. 1730, Cancer Drug Parity Act, regarding all provisions. S. 741, Cancer Drug Parity Act,regarding all provisions. H.R. 2279 / S.2546, Safe Step Act, issues relating to Step Therapy / Fail First. HR 965 / S. 340, CREATES Act, provisions regarding REMS. S. 2543, Prescription Drug Pricing Reduction Act of 2019, provisions regarding Medicare Part D / Part B. Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies. Issues relating to Medicare Reimbursement and Medicare Part D / Part B.

Duration: to

General Issues: Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (Domestic & Foreign), Medicare/Medicaid, Budget/Appropriations, Science/Technology

Spending: about $21,838,000 (But it's complicated. Here's why.)

Agencies lobbied since 2008: U.S. Senate, House of Representatives, U.S. Trade Representative (USTR), State - Dept of (DOS), Patent & Trademark Office (PTO), Health & Human Services - Dept of (HHS), Commerce - Dept of (DOC), Internal Revenue Service (IRS), Justice - Dept of (DOJ), Food & Drug Administration (FDA), Treasury - Dept of, Veterans Affairs - Dept of (VA), Centers For Medicare and Medicaid Services (CMS)

Bills mentioned

H.R.2051: FAST Generics Act of 2017

Sponsor: David McKinley (R-W.Va.)

H.R.1409: Cancer Drug Parity Act of 2017

Sponsor: Leonard Lance (R-N.J.)

H.R.2077: Restoring the Patient's Voice Act of 2017

Sponsor: Brad Wenstrup (R-Ohio)

S.974: Creating and Restoring Equal Access to Equivalent Samples Act of 2018

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.849: Protecting Seniors Access to Medicare Act

Sponsor: Phil Roe (R-Tenn.)

S.1390: STRONGER Patents Act of 2017

Sponsor: Christopher A. Coons (D-Del.)

H.R.2841: Disarm Hate Act

Sponsor: David Cicilline (D-R.I.)

H.R.2739: BE HEARD Act

Sponsor: Michael R. Turner (R-Ohio)

S.1566: CARE for Reservists Act of 2017

Sponsor: Jon Tester (D-Mont.)

H.R.1600: Veterans Back to Work Act of 2017

Sponsor: Ted Poe (R-Texas)

H.R.9: Innovation Act

Sponsor: Robert W. Goodlatte (R-Va.)

S.632: STRONG Patents Act of 2015

Sponsor: Christopher A. Coons (D-Del.)

H.R.2841: FAST Generics Act of 2015

Sponsor: Steve Stivers (R-Ohio)

H.R.2739: Cancer Drug Coverage Parity Act of 2015

Sponsor: Leonard Lance (R-N.J.)

S.1566: Cancer Drug Coverage Parity Act of 2015

Sponsor: Mark Steven Kirk (R-Ill.)

H.R.1600: Patients' Access to Treatments Act of 2015

Sponsor: David McKinley (R-W.Va.)

S.3056: CREATES Act of 2016

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.5657: FAST Generics Act of 2014

Sponsor: Steve Stivers (R-Ohio)

H.R.460: Patients' Access to Treatments Act of 2013

Sponsor: David McKinley (R-W.Va.)

H.R.1801: Cancer Drug Coverage Parity Act of 2013

Sponsor: Brian Higgins (D-N.Y.)

H.R.3116: MODDERN Cures Act of 2013

Sponsor: Leonard Lance (R-N.J.)

H.R.3309: Innovation Act

Sponsor: Robert W. Goodlatte (R-Va.)

S.1720: Patent Transparency and Improvements Act of 2013

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.3091: MODDERN Cures Act of 2013

Sponsor: Leonard Lance (R-N.J.)

H.R.3673: Family Cord Blood Banking Act

Sponsor: Aaron Schock (R-Ill.)

S.1871: SGR Repeal and Medicare Beneficiary Access Act of 2013

Sponsor: Max Baucus (D-Mont.)

H.R.3757: Igniting American Research Act

Sponsor: Scott Peters (D-Calif.)

H.R.1249: Leahy-Smith America Invents Act

Sponsor: Lamar Smith (R-Texas)

S.23: America Invents Act

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.2672: Preserving Access to Orphan Drugs Act of 2011

Sponsor: Jim Gerlach (R-Pa.)

S.1423: Preserving Access to Orphan Drugs Act of 2011

Sponsor: Patrick J. Toomey (R-Pa.)

S.1239: 340B Program Improvement and Integrity Act of 2009

Sponsor: Jeff Bingaman (D-N.M.)

H.R.444: 340B Program Improvement and Integrity Act of 2009

Sponsor: Bobby L. Rush (D-Ill.)

H.R.2212: CREATES Act of 2017

Sponsor: Tom Marino (R-Pa.)

H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the...

Sponsor: Kevin Brady (R-Texas)

H.R.985: FAST Generics Act of 2019

Sponsor: Peter Welch (D-Vt.)

H.R.1730: Cancer Drug Parity Act of 2019

Sponsor: Brian Higgins (D-N.Y.)

S.741: Cancer Drug Parity Act of 2019

Sponsor: Tina Smith (D-Minn.)

H.R.2279: Safe Step Act

Sponsor: Raul Ruiz (D-Calif.)

H.R.965: CREATES Act of 2019

Sponsor: David Cicilline (D-R.I.)

S.340: CREATES Act of 2019

Sponsor: Patrick J. Leahy (D-Vt.)

S.2543: Prescription Drug Pricing Reduction Act of 2019

Sponsor: Charles E. Grassley (R-Iowa)

S.2546: Safe Step Act

Sponsor: Lisa Murkowski (R-Alaska)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Alan F Eisenberg Congressional Staff, Rep. Greenwood, 2001-2004
ALAN EISENBERG Congressional Staff, Rep. Greenwood, 2001-2004
Alan F. Eisenberg Congressional Staff, Rep. Greenwood, 2001-2004
Anne Marie Finley US House of Representatives, Food and Drug Adm US House of Representatives, Food and Drug Admi
Robert Dole US Senate
Greg Chesmore Health Insurance Specialist 1999-2004, U.S. Department of Health and Human Services; Manager, Public Affairs 2004-2006, U.S. Department of Health and Human Services.
Stephen Rubright Legislative Assistant, Congressman Jeff Miller (Sept. 2007-May 2009); Legislative Assistant, Senator Kay Bailey Hutchinson (May 2009-February 2010)
ALANNA TEMME Legislative Director - Office of Jon C. Porter January 2006-December 2008 Legislative Assistant - Committee on Education and the Workforce - August 2003- July 2004 Staff Assistant - Committee on Financial Services - August 2002-July 2003.
Matthew Schumaker n/a
Patrick Gliha n/a
Erin Polak n/a
Richard T Girards Jr n/a
Richard T. Girards Jr n/a
Richard T. Girards Jr. n/a
Richard Thomas Girards Jr n/a
Jennifer Butler n/a
Mark Rayder n/a
Joseph Gibson n/a
Helen Fitzpatrick n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Amendment
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Amendment
Amendment
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page